Compare FANG & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FANG | CI |
|---|---|---|
| Founded | 2007 | 1792 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.3B | 79.0B |
| IPO Year | 2012 | 2018 |
| Metric | FANG | CI |
|---|---|---|
| Price | $201.04 | $278.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 24 | 15 |
| Target Price | $213.82 | ★ $349.00 |
| AVG Volume (30 Days) | 1.8M | ★ 2.0M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | 2.05% | ★ 2.13% |
| EPS Growth | N/A | ★ 83.00 |
| EPS | 6.72 | ★ 12.55 |
| Revenue | $15,026,000,000.00 | ★ $274,900,000,000.00 |
| Revenue This Year | $12.05 | $5.91 |
| Revenue Next Year | N/A | $5.92 |
| P/E Ratio | $29.89 | ★ $22.10 |
| Revenue Growth | ★ 35.79 | 11.24 |
| 52 Week Low | $134.30 | $239.51 |
| 52 Week High | $214.51 | $315.47 |
| Indicator | FANG | CI |
|---|---|---|
| Relative Strength Index (RSI) | 56.40 | 45.59 |
| Support Level | $170.43 | $266.41 |
| Resistance Level | $210.49 | $293.44 |
| Average True Range (ATR) | 5.69 | 8.04 |
| MACD | 0.11 | -1.15 |
| Stochastic Oscillator | 62.42 | 34.09 |
Diamondback is a crude oil and natural gas exploration and production firm whose operations represent a pure-play in the US Permian Basin. The company went public in 2012 and has established itself as a top-tier independent producer through disciplined acquisition and operational excellence. The company's most transformational transaction occurred in September 2024 with the completion of its $26 billion merger with Endeavor Energy Resources, which added around 470,000 net acres and doubled Diamondback's total acreage position. Diamondback boasts an enviable position in the Midland sub-basin, with some of the lowest unit costs among its Permian peers.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.